![John Donatello Manieri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Donatello Manieri
Nessuna posizione attualmente
Storia della carriera di John Donatello Manieri
Precedenti posizioni note di John Donatello Manieri
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bellevue Asset Management AG
![]() Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Gestore di Portafoglio-Azioni | 01/01/2015 | - |
COSMO PHARMACEUTICALS N.V. | Contatto Relazioni con gli Investitori | 01/05/2017 | - |
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Analyst-Equity | 01/05/2001 | - |
Gestore di Portafoglio-Azioni | 05/10/2011 | - |
Formazione di John Donatello Manieri
The University of Chicago Booth School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
Svizzera | 3 |
Irlanda | 2 |
Stati Uniti | 2 |
Posizioni
Portfolio Manager-Equities | 2 |
Analyst-Equity | 1 |
Investor Relations Contact | 1 |
Settori
Finance | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
COSMO PHARMACEUTICALS N.V. | Health Technology |
Aziende private | 2 |
---|---|
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Finance |
Bellevue Asset Management AG
![]() Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |